Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma
Crossref DOI link: https://doi.org/10.1007/s00280-014-2539-0
Published Online: 2014-08-07
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Motzer, Robert J.
Hutson, Thomas E.
Hudes, Gary R.
Figlin, Robert A.
Martini, Jean-Francois
English, Patricia A.
Huang, Xin
Valota, Olga
Williams, J. Andrew
License valid from 2014-08-07